UIP5 Antibody

What is UIP5/UBOX5 and why is it important in cellular research?

UIP5/UBOX5 is a protein containing a U-box domain that functions in the ubiquitin/proteasome system. It contains one RING-type zinc finger and one U-box domain, which are critical for its function. This protein interacts with UBCH7 (also known as UBE2L3), an enzyme that mediates selective degradation of abnormal proteins through the ubiquitination pathway . The gene encoding UIP5 is located on chromosome 20, which contains approximately 600 genes associated with various disorders including Creutzfeldt-Jakob disease, amyotrophic lateral sclerosis, and spinal muscular atrophy .

As a component of the ubiquitin-proteasome system, UIP5/UBOX5 plays critical roles in protein quality control, cell cycle regulation, and cellular stress response. Its involvement in protein degradation pathways makes it an important target for researchers studying proteostasis, neurodegenerative diseases, and cancer biology.

What types of UIP5/UBOX5 antibodies are available for research?

Several types of UIP5/UBOX5 antibodies are available for research purposes. The most common is the polyclonal rabbit antibody, which offers high sensitivity for detecting UIP5/UBOX5 in multiple applications. For instance, Anti-UBOX5 Rabbit Polyclonal Antibody is commercially available and has been validated for immunohistochemistry and immunofluorescence applications .

These antibodies typically recognize specific epitopes within the UIP5/UBOX5 protein. For example, one commercial antibody uses an immunogen sequence that includes: "FTLVGKVLLK NQSQVVFSHR GFKARPPFGA MEATLPSPAV VAQELWNKGA LSLSHVAHLR ICITHVTGGG IPCIKRLEVW GQPAKTCSQE VIDSILLVTS ENLPQDVALQ APALPMESDC DP" . This particular antibody has highest sequence identity to mouse (84%) and rat (80%) orthologs, making it suitable for cross-species research .

What applications are UIP5/UBOX5 antibodies most commonly used for?

UIP5/UBOX5 antibodies are utilized across various research applications, primarily:

• Western Blotting: For detecting and quantifying UIP5/UBOX5 protein expression levels in cell or tissue lysates.

• Immunohistochemistry (IHC): To visualize the distribution and localization of UIP5/UBOX5 in tissue sections. The recommended dilution range for IHC-P (paraffin-embedded tissues) is typically 1:100-500 .

• Immunofluorescence (IF): For subcellular localization studies, with recommended dilutions around 1:50-200 for paraffin-embedded tissues .

• Immunoprecipitation (IP): To isolate UIP5/UBOX5 and its binding partners for studying protein-protein interactions within the ubiquitination machinery.

• Chromatin Immunoprecipitation (ChIP): For researchers investigating potential roles of UIP5/UBOX5 in transcriptional regulation or chromatin-associated functions.

When selecting an antibody for a specific application, researchers should consider factors such as species reactivity, clonality, and validation data provided by manufacturers to ensure optimal results.

How should UIP5/UBOX5 antibodies be validated before use in critical experiments?

Proper validation of UIP5/UBOX5 antibodies is crucial for ensuring reliable experimental results. A comprehensive validation approach should include:

• Positive and Negative Controls:

  • Positive: Tissues or cell lines known to express UIP5/UBOX5

  • Negative: Tissues or knockout/knockdown cells lacking UIP5/UBOX5 expression

• Cross-Reactivity Testing: Evaluate potential cross-reactivity with related proteins, particularly other U-box domain-containing proteins or RING finger proteins. Comprehensive specificity analysis using techniques like those employed in multiplex antibody assays can help determine cross-reactivity profiles .

• Multiple Detection Methods: Confirm results using at least two independent detection methods (e.g., Western blot and immunofluorescence).

• Peptide Competition Assay: Pre-incubate the antibody with excess immunizing peptide to confirm specificity of binding.

• Antibody Titration: Determine optimal working concentrations through serial dilutions to maximize signal-to-noise ratio.

• Orthogonal Validation: Compare results with other antibodies targeting different epitopes of UIP5/UBOX5 or with non-antibody methods like mass spectrometry.

This rigorous validation approach helps ensure that observed signals truly represent UIP5/UBOX5 rather than non-specific binding or artifacts.

What are the best protocols for using UIP5/UBOX5 antibodies in Western blotting?

For optimal Western blotting results with UIP5/UBOX5 antibodies, follow this methodological approach:

• Sample Preparation:

  • Extract proteins using RIPA buffer supplemented with protease inhibitors

  • Include phosphatase inhibitors if studying phosphorylation states

  • Typical protein loading: 20-40 μg per lane

• Gel Electrophoresis and Transfer:

  • Use 10% SDS-PAGE gels (UIP5/UBOX5 has a molecular weight of approximately 62 kDa)

  • Transfer to PVDF membrane (preferred over nitrocellulose for this protein)

  • Transfer at 100V for 60-90 minutes in ice-cold transfer buffer

• Blocking and Antibody Incubation:

  • Block with 5% non-fat dry milk in TBST for 1 hour at room temperature

  • Primary antibody dilution: 1:500-1:2000 (optimize based on specific antibody)

  • Incubate overnight at 4°C with gentle rocking

  • Wash 3-5 times with TBST, 5 minutes each

  • Secondary antibody: Anti-rabbit HRP (1:5000-1:10000)

  • Incubate for 1 hour at room temperature

• Detection and Analysis:

  • Use ECL substrate for detection

  • Expected band size: ~62 kDa for full-length UIP5/UBOX5

  • Multiple bands may indicate splice variants (as alternate splicing results in multiple transcript variants)

• Controls:

  • Loading control: β-actin or GAPDH

  • Positive control: HEK293 cells (known to express UIP5/UBOX5)

This protocol should be optimized for individual laboratory conditions and specific antibody characteristics.

How can I troubleshoot non-specific binding when using UIP5/UBOX5 antibodies?

Non-specific binding is a common challenge when working with antibodies. For UIP5/UBOX5 antibodies specifically, consider these troubleshooting approaches:

• Increase Blocking Stringency:

  • Use 5% BSA instead of milk for blocking if background is high

  • Consider adding 0.1-0.3% Triton X-100 to reduce hydrophobic interactions

  • Extend blocking time to 2 hours at room temperature

• Antibody Optimization:

  • Further dilute primary antibody (1:2000-1:5000)

  • Reduce incubation time or temperature

  • Try different antibody clones targeting different epitopes

• Buffer Modifications:

  • Increase salt concentration in wash buffer (up to 500 mM NaCl)

  • Add 0.1% SDS to TBST for Western blot applications

  • Use high-quality, freshly prepared buffers

• Pre-adsorption Techniques:

  • Pre-incubate antibody with tissues or cell lysates lacking the target

  • Use commercially available antibody pre-adsorption kits

• Sample Preparation Improvements:

  • Ensure complete protein denaturation

  • Filter lysates to remove particulates

  • Perform additional clarification centrifugation steps

For particularly challenging samples, modern computational approaches similar to those used in antibody specificity design could help identify potential cross-reactive epitopes and inform experimental design modifications .

How can I use UIP5/UBOX5 antibodies to study protein-protein interactions in the ubiquitination pathway?

UIP5/UBOX5 antibodies can be powerful tools for investigating protein-protein interactions within the ubiquitination pathway using these methodological approaches:

• Co-Immunoprecipitation (Co-IP):

  • Lyse cells in non-denaturing buffer to preserve protein complexes

  • Pre-clear lysate with Protein A/G beads

  • Incubate with UIP5/UBOX5 antibody overnight at 4°C

  • Capture complexes with fresh Protein A/G beads

  • Elute and analyze binding partners by mass spectrometry or Western blotting

  • Look specifically for known interactors like UBCH7

• Proximity Ligation Assay (PLA):

  • Use UIP5/UBOX5 antibody alongside antibodies against suspected interacting partners

  • Follow established PLA protocols to visualize interactions in situ

  • Quantify interaction signals through fluorescence microscopy

• Bimolecular Fluorescence Complementation (BiFC):

  • Clone UIP5/UBOX5 and potential interacting proteins with split fluorescent protein tags

  • Transfect cells and analyze reconstituted fluorescence

  • Use antibodies to confirm expression levels of fusion proteins

• FRET-based Approaches:

  • Label UIP5/UBOX5 antibody and interaction partner antibodies with appropriate FRET pairs

  • Measure energy transfer to confirm proximity-based interactions

When studying these interactions, researchers should consider the dynamic nature of the ubiquitination pathway. For example, proteasome inhibitors like MG132 can be used to stabilize ubiquitinated proteins and enhance detection of transient interactions.

What are the considerations for using UIP5/UBOX5 antibodies in studying neurodegenerative diseases?

Given the potential involvement of the ubiquitin-proteasome system in neurodegenerative disorders and UIP5/UBOX5's location on chromosome 20 (associated with several neurological conditions) , UIP5/UBOX5 antibodies can be valuable tools in neurodegenerative disease research:

• Tissue-Specific Considerations:

  • Brain tissue often requires specialized fixation protocols

  • For IHC, antigen retrieval is critical (citrate buffer pH 6.0 recommended)

  • Background autofluorescence can be reduced with Sudan Black treatment

  • Consider using tyramide signal amplification for low-abundance detection

• Disease Model Systems:

  • Animal models of neurodegeneration may express different levels of UIP5/UBOX5

  • Validate antibody specificity in each model system

  • Use multiple antibodies targeting different epitopes to confirm findings

• Co-localization Studies:

  • Combine UIP5/UBOX5 antibodies with markers for:

    • Protein aggregates (e.g., tau, α-synuclein, huntingtin)

    • Neuronal/glial cell types

    • Subcellular compartments

• Quantitative Approaches:

  • Use digital image analysis for objective quantification

  • Consider multiplex approaches to assess relationships with multiple markers

  • Single-cell analysis can reveal cell-type specific patterns

• Controls for Neurodegenerative Research:

  • Age-matched controls are essential

  • Include both disease and non-disease regions from the same subject

  • Consider post-mortem interval effects on protein stability

This research may provide insights into how dysfunction in the ubiquitin-proteasome system contributes to protein aggregation and neurodegeneration.

How can UIP5/UBOX5 antibodies be used in multiplex immunoassays for systems biology research?

Modern systems biology approaches often require simultaneous detection of multiple proteins. UIP5/UBOX5 antibodies can be incorporated into multiplex assays using these methodological considerations:

• Bead-Based Multiplex Platforms:

  • Similar to techniques used for SARS-CoV-2 antibody detection , UIP5/UBOX5 antibodies can be conjugated to uniquely identifiable microspheres

  • Each bead population can be coated with a different antibody targeting various components of the ubiquitination pathway

  • Flow cytometry-based detection allows simultaneous quantification of multiple proteins

  • Typical sensitivity and specificity metrics should reach >90% when optimized

• Multiplexed Immunofluorescence:

  • Use antibodies with non-overlapping species or isotypes

  • Employ sequential staining protocols with tyramide signal amplification

  • Use spectral unmixing to separate closely overlapping fluorophores

  • Include appropriate controls for each antibody in the panel

• Data Analysis Approaches:

  • Apply machine learning algorithms for pattern recognition

  • Use hierarchical clustering to identify co-regulated proteins

  • Implement network analysis to visualize protein interaction landscapes

• Validation in Single-Cell Studies:

  • Confirm multiplex findings with single-cell techniques

  • Consider CyTOF (mass cytometry) for higher multiplexing capacity

  • Validate with orthogonal methods like single-cell RNA-seq

• Cross-Platform Standardization:

  • Use reference standards across experimental batches

  • Include spike-in controls for normalization

  • Develop standard curves for absolute quantification

This table provides a comparison of various multiplex techniques that could incorporate UIP5/UBOX5 antibodies for systems biology research.

How should I design experiments to study UIP5/UBOX5 expression across different cellular conditions?

Studying UIP5/UBOX5 expression across various cellular conditions requires careful experimental design:

• Cellular Stress Conditions to Consider:

  • Proteasome inhibition (MG132, bortezomib)

  • Oxidative stress (H₂O₂, paraquat)

  • ER stress (tunicamycin, thapsigargin)

  • Heat shock

  • Nutrient deprivation/starvation

• Time Course Considerations:

  • Include multiple time points (0, 2, 6, 12, 24, 48 hours)

  • Perform both acute and chronic exposure studies

  • Consider recovery phases after stress removal

• Comprehensive Expression Analysis:

  • Analyze both protein (Western blot, IF) and mRNA (qPCR) levels

  • Include assessment of post-translational modifications

  • Monitor subcellular localization changes

  • Evaluate presence of splice variants

• Controls and Normalization:

  • Use multiple housekeeping genes/proteins as references

  • Include positive controls (proteins known to respond to each stressor)

  • Normalize to total protein loading (Ponceau, REVERT)

  • Consider ratiometric measurements for phosphorylation studies

• Statistical Design:

  • Minimum of 3-5 biological replicates

  • Power analysis to determine sample size

  • Appropriate statistical tests based on data distribution

  • Multiple testing correction for large-scale studies

This comprehensive approach allows for robust analysis of how UIP5/UBOX5 responds to various cellular perturbations, potentially revealing functional insights.

What are the best approaches for studying UIP5/UBOX5 function using antibody-based techniques?

To elucidate UIP5/UBOX5 function using antibody-based approaches, consider these methodological strategies:

• Functional Blocking Studies:

  • Microinjection of antibodies to block specific protein domains

  • Combine with live-cell imaging to monitor effects on ubiquitination processes

  • Use Fab fragments for better cellular penetration

  • Include non-specific IgG controls

• Proximity-Based Proteomics:

  • BioID or APEX2 proximity labeling fused to UIP5/UBOX5

  • Antibody-based purification of biotinylated proteins

  • Mass spectrometry identification of the proximal proteome

  • Validation of key interactions with Co-IP using UIP5/UBOX5 antibodies

• Chromatin-Associated Function Analysis:

  • ChIP-seq to identify potential DNA binding sites

  • Re-ChIP to study co-occupancy with transcription factors

  • CUT&RUN for higher resolution mapping

  • Validation of binding sites with reporter assays

• Degradation Dynamics:

  • Cycloheximide chase combined with UIP5/UBOX5 antibodies

  • Pulse-chase experiments with metabolic labeling

  • Proteasome inhibitor studies (MG132)

  • Ubiquitination assays with antibodies against UIP5/UBOX5 and ubiquitin

• Structure-Function Analysis:

  • Epitope mapping to identify functional domains

  • Competition assays with domain-specific peptides

  • Conformation-specific antibodies to detect active/inactive states

  • FRET-based sensors to monitor conformational changes

These approaches leverage the specificity of antibodies to provide insights into UIP5/UBOX5's functional roles in the ubiquitin-proteasome system.

How can I develop robust data analysis pipelines for UIP5/UBOX5 antibody-based imaging studies?

Developing robust analytical pipelines for UIP5/UBOX5 antibody-based imaging requires systematic approaches similar to those used in data table analysis for recipe performances :

• Image Acquisition Standardization:

  • Fixed exposure settings across experimental conditions

  • Z-stack acquisition for 3D analysis

  • Multi-channel acquisition with spectral separation

  • Include flatfield correction and background controls

• Preprocessing Pipeline:

  • Background subtraction and illumination correction

  • Deconvolution for improved signal-to-noise

  • Channel alignment and registration

  • Drift correction for time-lapse studies

• Segmentation Strategies:

  • Nuclear segmentation with DAPI/Hoechst

  • Cell boundary detection with membrane markers

  • Subcellular compartment identification

  • Spot detection for punctate UIP5/UBOX5 signals

• Quantification Parameters:

  • Signal intensity (mean, integrated, background-corrected)

  • Object counts and morphometrics

  • Colocalization metrics (Pearson's, Manders', object-based)

  • Distance measurements between objects

• Advanced Analysis Approaches:

  • Machine learning classification of phenotypes

  • Trajectory analysis for dynamic studies

  • Spatial statistics for pattern recognition

  • Network analysis for multi-protein studies

• Validation and Quality Control:

  • Technical replicate consistency assessment

  • Biological replicate variation analysis

  • Sensitivity analysis for parameter settings

  • Orthogonal validation with non-imaging techniques

This systematic approach ensures reproducible and reliable quantification of UIP5/UBOX5 expression and localization patterns in imaging studies.

How might emerging antibody technologies improve UIP5/UBOX5 research?

Recent advances in antibody technology offer exciting opportunities for UIP5/UBOX5 research:

• Bispecific Antibodies for Enhanced Detection:
  Similar to approaches used for SARS-CoV-2 variants , bispecific antibodies targeting both UIP5/UBOX5 and its interaction partners could provide:

  • Improved sensitivity for detecting protein complexes

  • Ability to track specific functional states

  • Enhanced signal-to-noise in challenging samples

  • Detection of conformational changes upon binding

• Computationally Designed Antibodies:
  Using inference and design approaches similar to those described for antibody specificity :

  • Custom-tailored antibodies with predicted binding profiles

  • Antibodies specifically targeting distinct splice variants

  • Enhanced specificity through computational epitope mapping

  • Reduced cross-reactivity with related U-box proteins

• Nanobodies and Single-Domain Antibodies:

  • Smaller size allowing access to restricted epitopes

  • Improved penetration in live-cell applications

  • Reduced immunogenicity for in vivo applications

  • Easier genetic manipulation for fusion proteins

• Epitope-Tagged Approaches:
  Drawing from advances in epitope tagging systems :

  • CRISPR-mediated endogenous tagging of UIP5/UBOX5

  • Multiplexed detection with orthogonal tag antibodies

  • Split-tag approaches for protein interaction studies

  • Highly reproducible standardized detection

• Antibody-Based Biosensors:

  • FRET-based conformational sensors

  • Activity-based probes for monitoring enzymatic function

  • Optogenetic antibody systems for spatiotemporal control

  • Antibody-conjugated quantum dots for long-term tracking

These emerging technologies promise to expand the toolkit available for UIP5/UBOX5 research, enabling more sophisticated analyses of its functions and interactions.

What are the most promising research directions for UIP5/UBOX5 in disease pathology?

Based on current knowledge about UIP5/UBOX5 and its role in the ubiquitin-proteasome system, several promising research directions emerge:

• Neurodegenerative Disorders:
  Given UIP5/UBOX5's location on chromosome 20, which is associated with several neurological conditions :

  • Investigation of UIP5/UBOX5 expression in Alzheimer's, Parkinson's, and ALS models

  • Analysis of potential roles in protein aggregate clearance

  • Examination of genetic variants in patient populations

  • Development of therapeutic strategies targeting UIP5/UBOX5 pathways

• Cancer Biology:

  • Characterization of UIP5/UBOX5 alterations across cancer types

  • Identification of oncogenic proteins regulated by UIP5/UBOX5

  • Analysis of chemotherapy resistance mechanisms involving the ubiquitin system

  • Development of UIP5/UBOX5-based cancer biomarkers

• Cellular Stress Response:

  • Investigation of UIP5/UBOX5's role in various stress conditions

  • Analysis of post-translational modifications regulating its activity

  • Characterization of stress-specific interaction networks

  • Development of stress-responsive biosensors

• Developmental Biology:

  • Mapping UIP5/UBOX5 expression during embryonic development

  • Analysis of knockout/knockdown phenotypes in model organisms

  • Investigation of roles in stem cell maintenance and differentiation

  • Characterization of tissue-specific functions

• Therapeutic Development:

  • Identification of small molecules targeting UIP5/UBOX5 activity

  • Development of protein-protein interaction inhibitors

  • Exploration of gene therapy approaches

  • Design of antibody-drug conjugates for targeted delivery

These research directions could significantly advance our understanding of UIP5/UBOX5's role in health and disease, potentially leading to new diagnostic and therapeutic approaches.

How can I integrate UIP5/UBOX5 antibody data with other -omics approaches for systems-level insights?

Integrating antibody-based UIP5/UBOX5 data with other -omics approaches enables comprehensive systems-level understanding:

• Multi-omics Data Integration Framework:

  • Combine UIP5/UBOX5 antibody data with transcriptomics, proteomics, and metabolomics

  • Develop computational pipelines for cross-platform normalization

  • Apply network analysis to identify regulatory relationships

  • Use machine learning for pattern recognition across datasets

• Spatially Resolved Multi-omics:

  • Correlate UIP5/UBOX5 immunofluorescence with spatial transcriptomics

  • Implement image registration algorithms for proper alignment

  • Develop cell type-specific analyses using markers

  • Apply neighborhood analysis to identify spatial patterns

• Temporal Multi-omics:

  • Design time-course experiments capturing UIP5/UBOX5 dynamics

  • Implement time-delay correlation analysis

  • Use differential equation modeling for dynamic relationships

  • Develop state transition models based on integrated data

• Perturbation-Based Approaches:

  • Combine UIP5/UBOX5 knockdown/overexpression with multi-omics profiling

  • Implement causal inference methods to establish directionality

  • Develop network perturbation models

  • Identify compensatory mechanisms through integrative analysis

• Data Visualization and Exploration Tools:

  • Develop interactive visualization platforms for integrated data

  • Implement dimensionality reduction for complex dataset exploration

  • Create pathway-centric visualization approaches

  • Design cell-state mapping based on multi-modal data

This integrative approach enables researchers to place UIP5/UBOX5 function within broader cellular contexts, revealing emergent properties not apparent from any single data type.